Following hyperuricemia induction, we administered treatments including uricosuric controls (benzbromarone and probenecid) for the UA quantification assay and an XO inhibitor (allopurinol) for the XO quantification assay and treated the experimental groups with LIPO + EREC or LIPO + GOIA. This evidence concerns the gene XDH and hyperuricemia.